Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Emerald if you stop posting for a few days, the price would go up. You are putting people off with your constant ramping. I am long and hold angle
Looks good
Dummy Sell offering me 19.2569, not long now before the blue wave.
EC you're trying way too hard again... 😆 lol!
Making tens of millions from follow on contracts with Eisai and Astrazeneca I think any bid rumours could turn out to be be true. The sp makes Angle dirt cheap. Maybe the next RNS will be about an offer from Illumina?? That would make sense to me. Or Thermo Fisher?
All IMHO.
Ticked up.
The results delay could be anything.
Is there yet another announcement from a "household" name they want to put out first?
Have they received a bid?
My guess is they want to finish the discussions with these other 11 Companies (2 of them "household names") before they release the results...... Hmm. In fact one might think there IS another huge announcement to come WITH THE RESULTS. Co's usually like to have a good news RNS with their results don't they!! Very likely!!
All IMHO.
Hi EC, I agree that they have cash until Q2 2025 so no rush. However why the delay in results? something does not seem right? Maybe poor results? Anyway god luck. I no longer hold. I will assess my position after results.
Runway was expected to last at least until Q2 2025. The latest presentation speaks of 11 other potential customers, two of which are household names. If I were management at Angle I would wait to see how things pan out over the next 6 months. If it goes well a placing may not be needed. Also we might get bought out by the likes of Illumina or Therme Fisher!!
All IMHO.
Fevertreeman, in addition to the contracts you also need to factor in the existing ongoing lab services work for other clients, plus the product sales - there will be decent income form these too.
Be careful here imo. Angle should have released results by now. Are they holding off with release recent news to bump up sp ahead of poor results or placing? If you want to Buy/Sell good luck just something to think about...
So there is very good reason to think more similar contracts are in the pipeline. The last Astrazeneca one was for £550,000 and could end up in the tens of milions if the cancer drug trial goes to phase II, III and IV. Angle maybe late, but they are starting to deliver the goods. Astrazeneca and Eisai are two of the biggest Pharma Co's in the entire World!
See video here:-
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
All IMHO,
Fevertreeman
Think you will find those contracts are one off payments.
HoofofHeartAgain
Another spoof account it's infectious!.
Member Since
16th Nov 2020
Joined 3 days earlier than 'ThePhony' what a remarkable coincidence and with 18 posts in 3.5 years!
ThePhony
Member Since
20th Nov 2020
Member fir over 3 5 years with 3 posts you look like a Phony account lol!..🙂
I filtered both of them a while ago and the board is so much better to view without seeing their posts.
Always has that whiff with Nero doesn't it. Fair do's to him (or Swansinger) that they have signed up AZ with a meaningful contract. And I was happy to praise this swallow, knowing that summer is alway a long time coming (if it ever does) with Newland. As you correctly point out, Newland has a dreadful ftrack record of hyping but not delivering. And this was one of the reasons that big investors got totally disillusioned & sold out, but not until after being royally rogered by the post FDA 80p cash raise, soon after which Newland missed his own forecasts, and the sp slumped...
Newland went on record at the trading update in November: YE 2023 revenue c£2.2m, with "Revenue recognised for 2024 expected to treble compared to 2023" i.e. to £6.6m. True to form, Newland provided no detail or rationale as to why it would 3x - a classic Newland ploy.
So with Q1 over, how is AGL performing against Newland's own predictive scorecard of £6.6m YE 24 revs? I dont think one can be terribly reassured tbh. Year to date the revenues from contracts announces stands at just £900,000 i.e.
(Eisei ($250,000) ; AZ DDR assay (£150,000); AZ prostate detection assay (£550,000).
Pro-rating that for the full year gets one to £3.6m. So either the deal flow has to accelerate at a massive rate to meet Newland's target or they have to land some big whales.
I really don't understand your desire to post constantly about what a dog Angle is.
I do find it amusing that you do think SYME is worth your money though; despite it having issued over 62.5 billion shares and in death spiral finance and seemingly no customers.
.
Any chance you and EC can exchange contact details and both communicate privately thus sparing the forum your nonsense?
So they hopefully will join Astrazeneca and Eisai. This is just going to snowball now the industry knows for sure the likes of Astra and Eisai are working with Angle Plc. Loads of potential customers IN THE WORLD.
See video here:-
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
EC
Agreed
This is going to be huge. Don’t rule out another blue finish today. Remember you heard it here first! 😉
They should make a film call it the 'Wolf of Wall Street' staring Newland and based around how you go about hyping a bio penny stock by luring in punters with stories of untold riches and when you reel them in just let slip that to get to that promised land of milk and honey you just need another £20m in donations...I can tell you now that would be a great film plot!
Following on from the two with Astrazeneca and the one with Eisai Inc.
Totally obvious. The sp will top 25p within a few weeks IMHO.
Another one.
Yes, 25p finish
Do we have another big investor getting on board?
Hmm.